VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Third quarter numbers out next week

<< Previous

Bullboard Posts

Next >>

Comment by WalkOverTheStrton Nov 23, 2023 8:23am

45 Views

Post# 35749740

RE:Third quarter numbers out next week

A placement is a certainty and it will be brutal. Might wake up the ceo and GA to hire a sales exec who can try to fix their sales strategy (given neither have a sales background). Need 4.0 to come online to reduce the manual placement needs and then get Ascend partnership to selling mode. More questions than answers.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale